Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00118534 · ClinicalTrials.gov registry record · NA

Integrating Clinical Practice Guidelines for Smoking Cessation Into Mental Health Care for Veterans With Posttraumatic Stress Disorder

A NA study of Tobacco Use Disorder and Stress Disorders, Post-Traumatic, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
943
Enrollment target
11
Study locations

NCT00118534 is a NA study of Tobacco Use Disorder and Stress Disorders, Post-Traumatic that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 943 participants, above the 226-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (317% higher). The trial reports 11 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00118534, a NA study of Tobacco Use Disorder and Stress Disorders, Post-Traumatic, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
943 participants
Enrollment target
11
Study locations

Study Summary

The primary study objective is to conduct a prospective, randomized controlled clinical trial that compares the effectiveness of two approaches for delivering smoking cessation treatment for veterans with posttraumatic stress disorder (PTSD). An approach where smoking cessation treatment is integrated into mental health care for PTSD and delivered by mental health providers (experimental condition) will be compared to specialized smoking cessation clinic referral (VA's usual standard of care). Secondary study objectives are to (a) compare the cost outcomes and cost-effectiveness of IC versus USC, (b) identify treatment process variables that explain (mediate) observed differences in smoking abstinence rates for the two study conditions, and (c) determine whether cessation from smoking is associated with worsening of symptoms of PTSD and/or depression.

Interventions

  • BEHAVIORAL Standard of Care
  • BEHAVIORAL Integrated Care for Smoking Cessation in PTSD patients

Study Locations (11)

Alabama

  • VA Medical Center, Tuscaloosa - Tuscaloosa

California

  • VA San Diego Healthcare System, San Diego - San Diego

District of Columbia

  • VA Medical Center, DC - Washington D.C.

Louisiana

  • Southeast Veterans Healthcare System, New Orleans - New Orleans

Minnesota

  • VA Medical Center, Minneapolis - Minneapolis

Oregon

  • VA Medical Center, Portland - Portland

Pennsylvania

  • VA Medical Center, Philadelphia - Philadelphia

Rhode Island

  • VA Medical Center, Providence - Providence

Trial Details

FieldValue
Enrollment Target 943 participants
Start Date 2004-07
Est. Completion 2009-06
Phase NA

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00118534

The ClinicalTrials.gov registry entry for NCT00118534 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 943 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 226-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (317% higher). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Tobacco Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT00118534 reports 11 study locations spanning 11 distinct geographic areas - top geographies include Alabama, California, District of Columbia.

Frequently Asked Questions

What is clinical trial NCT00118534 about?

NCT00118534 is a clinical study titled "Integrating Clinical Practice Guidelines for Smoking Cessation Into Mental Health Care for Veterans With Posttraumatic Stress Disorder". The primary study objective is to conduct a prospective, randomized controlled clinical trial that compares the effectiveness of two approaches for delivering smoking cessation treatment for veterans with posttraumatic stress disorder (PTSD). An approach where smoking cessation treatment is integrat...

What is the current status of trial NCT00118534?

This trial is currently completed. It is a NA study. The enrollment target is 943 participants. The study started on 2004-07. Estimated completion is 2009-06.

What conditions does trial NCT00118534 study?

This clinical trial studies the following conditions: Tobacco Use Disorder, Stress Disorders, Post-Traumatic, Substance-Related Disorders, Mental Health.

What interventions are being tested in trial NCT00118534?

The interventions under investigation include: Standard of Care (BEHAVIORAL), Integrated Care for Smoking Cessation in PTSD patients (BEHAVIORAL).

Who is sponsoring clinical trial NCT00118534?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00118534 being conducted?

This trial has 11 study locations across Alabama, California, District of Columbia, Louisiana, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.